MaxCyte, Inc. Presents Unprecedented Data Using Flow Electroporation for CHO-Based Transient Gene Expression to Achieve Gram Scale Antibody Production and Rapid Stable Cell Line Generation

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance cell transfection systems, is hosting a series of events at IBC’s 9th Annual Cell Line Development & Engineering Conference being held May 20-22 in La Jolla, CA. During this cutting-edge conference on innovations for bioproduct development, MaxCyte will present breakthrough transient gene expression (TGE) data in a scientific podium presentation and detail unmatched novel antibody production capabilities in two technical posters. MaxCyte scientists will be available throughout the conference at Booth #12 to provide technical details on the use of flow electroporation for large scale transient gene expression and rapid stable cell line generation.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC